Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Statin therapy for diabetic patients

November 21, 2017

Both the 2017 American Diabetes Association (ADA) and the 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that all patients with diabetes ages 40 to 75 receive statin therapy regardless of LDL cholesterol levels.

Both sets of guidelines recommend either high- or moderate-intensity statins depending on specific patient factors.1,2

The ACC/AHA guidelines recommend a moderate-intensity statin for primary prevention in patients with diabetes mellitus and an LDL-C level of 70 ? 189 mg/dL. A high-intensity statin is recommended for this patient population if their ten-year atherosclerotic cardiovascular disease (ASCVD) risk is greater than 7.5 percent, a measure that is calculated using an online tool available through the ACC website.

In the event that a certain intensity statin is recommended but unable to be tolerated, a different statin or lower-intensity statin may be used in its place. There is evidence to suggest that statins provide benefits for diabetic patients, even at low less-than-daily doses.1

Statin therapy for patients with cardiovascular disease risk factors

The United States Preventive Services Task Force recommends initiating a low- to moderate-dose statin in patients ages 40 to 75 with no history of cardiovascular disease (CVD), one or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking), and a calculated ten-year CVD event risk of 10 percent or greater.3

In the event that a certain intensity statin is recommended but unable to be tolerated, a different statin or lower intensity statin may be used in its place.

Please note: This information is only current as of the date of publication.

1American Diabetes Association. ?Standards of medical care in diabetes ? 2017.? Diabetes Care. January 2017; 40 Suppl 1:S79-81.

2Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ?2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.? J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934.

3Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication. U.S. Preventive Services Task Force. November 2016. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/Reco mmendationStatementFinal/statin-use-in-adults-preventive-medication1. Accessed October 17, 2017.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.